ArticleBiopreservation and biobanking2014
A framework for biobank sustainability.
Article in Biopreservation and biobanking, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed.
- Paediatric biobanking in the era of precision medicine: ethical, regulatory, and scientific challenges from childhood to adulthood.European journal of pediatrics · 2026Review
- Review
- Utilization Patterns of Hospital Biobank Samples: Time to First Use and Material-Specific Demand.Journal of clinical medicine · 2026Article
- The case for an integrated biobanking initiative in South Asia.The Lancet regional health. Southeast Asia · 2026Review
- The Development of the Biobank Collections Valuator as an Automated Tool to Determine the Noneconomic Value of Sample Collections.Biopreservation and biobanking · 2026Article
- Nuclei Isolation Methods on Frozen Clotted Blood Samples.Bio-protocol · 2026Article
- Navigating tensions between scientific advancement and ethical practice in biobanking: a qualitative study in Japan.Frontiers in genetics · 2026Article
- Review
- Risk mapping for better governance in biobanking: the case of biobank.cy.Frontiers in genetics · 2024Article
- Establishing a Pregnancy Lyme Disease Biobank.Methods in molecular biology (Clifton, N.J.) · 2024Article
- Drivers and constraints to environmental sustainability in UK-based biobanking: balancing resource efficiency and future value.BMC medical ethics · 2023Article
- Stakeholder engagement to ensure the sustainability of biobanks: a survey of potential users of biobank services.European journal of human genetics : EJHG · 2022Article
- Integrating research infrastructures into infectious diseases surveillance operations: Focus on biobanks.Biosafety and health · 2022Article
- Purpose, Partnership, and Possibilities: The Implementation of the Dog Aging Project Biobank.Biomarker insights · 2022Article
- Sustainable biobanks: a case study for a green global bioethics.Global bioethics = Problemi di bioetica · 2022Article
- The Availability of Human Biospecimens to Support Biomarker Research.Biomarker insights · 2022Review
- Recommendations for a Dutch Sustainable Biobanking Environment.Biopreservation and biobanking · 2021Article
- Identifying the nature and extent of public and donor concern about the commercialisation of biobanks for genomic research.European journal of human genetics : EJHG · 2021Article
- Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability.Biomarker insights · 2021Article
- Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.Biopreservation and biobanking · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Each year funding agencies and academic institutions spend millions of dollars and euros on biobanking. All funding providers assume that after initial investments biobanks should be able to operate sustainably. However the topic of sustainability is challenging for the discipline of biobanking for several major reasons: the diversity in the biobanking landscape, the different purposes of biobanks, the fact that biobanks are dissimilar to other research infrastructures and the absence of universally understood or applicable value metrics for funders and other stakeholders. In this article our aim is to delineate a framework to allow more effective discussion and action around approaches for improving biobank sustainability. The term sustainability is often used to mean fiscally self-sustaining, but this restricted definition is not sufficient for biobanking. Instead we propose that biobank sustainability should be considered within a framework of three dimensions - financial, operational, and social. In each dimension, areas of focus or elements are identified that may allow different types of biobanks to distinguish and evaluate the relevance, likelihood, and impact of each element, as well as the risks to the biobank of failure to address them. Examples of practical solutions, tools and strategies to address biobank sustainability are also discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.